Positron Emission Tomography in Movement Disorders
Open Access
- 1 February 1985
- journal article
- review article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 12 (1) , 6-10
- https://doi.org/10.1017/s0317167100046515
Abstract
Positron emission tomography provides a method for the quantitation of regional function within the living human brain. Studies of cerebral metabolism and blood flow in patients with Huntington’s disease, Parkinson’s disease and focal dystonia have revealed functional abnormalities within substructures of the basal ganglia. Recent developments permit assessment of both pre-synaptic and post-synaptic function in dopaminergic pathways. These techniques are now being applied to studies of movement disorders in human subjects.Keywords
This publication has 27 references indexed in Scilit:
- Lesions of the putamen and dystoniaNeurology, 1984
- Drug and Neurotransmitter Receptors in the BrainScience, 1984
- External Imaging of Cerebral Muscarinic Acetylcholine ReceptorsScience, 1984
- Parkinson's disease: Metabolic and pharmacological approaches with positron emission tomographyAnnals of Neurology, 1984
- Dopamine visualized in the basal ganglia of living manNature, 1983
- Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission TomographyJournal of Computer Assisted Tomography, 1980
- Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the ratBrain Research, 1980
- The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.Circulation Research, 1979
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- Lesions of ascending dopaminergic pathways decrease forebrain glucose uptakeNature, 1976